Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives

Abstract

Alcohol-related liver disease (ALD) refers to a spectrum of liver manifestations ranging from fatty liver diseases, steatohepatitis, and fibrosis/cirrhosis with chronic inflammation primarily due to excessive alcohol use. Currently, ALD is considered as one of the most prevalent causes of liver disease-associated mortality worldwide. Although the pathogenesis of ALD has been intensively investigated, the present understanding of its biomarkers in the context of early clinical diagnosis is not complete, and novel therapeutic targets that can significantly alleviate advanced forms of ALD are limited. While alcohol abstinence remains the primary therapeutic intervention for managing ALD, there are currently no approved medications for treating ALD. Furthermore, given the similarities and the differences between ALD and non-alcoholic fatty liver disease in terms of disease progression and underlying molecular mechanisms, numerous studies have demonstrated that many therapeutic interventions targeting several signaling pathways, including oxidative stress, inflammatory response, hormonal regulation, and hepatocyte death play a significant role in ALD treatment. Therefore, in this review, we summarized several key molecular targets and their modes of action in ALD progression. We also described the updated therapeutic options for ALD management with a particular emphasis on potentially novel signaling pathways.

From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women

“…Furthermore, it is important to note that the GBD data, which highlight the impact of alcohol on liver cancer and cirrhosis, should not lead to believe that patients without cancer and cirrhosis are immune against hepatic injury caused by alcohol. This injury encompasses conditions such as steatosis, steatohepatitis, and fibrosis (56). Consequently, future research should focus on understanding the early impacts of alcohol on the liver.…”

Hovenia dulcis: a Chinese medicine that plays an essential role in alcohol-associated liver disease

“…Activated myofibroblasts produce mainly type I and type III collagen, which cross-links and accumulate in the extracellular matrix (ECM), replacing the injured liver parenchyma and forming a fibrous scar ( Bellanti et al, 2023 ). HSCs can be directly activated by alcohol, acetaldehyde, and ROS or in a paracrine manner by various fibrogenic factors (e.g., transforming growth factor-β, platelet-derived growth factor, and inflammatory cytokines) released from damaged hepatocytes, activated Kupffer cells, and infiltrated immune cells ( Ha et al, 2022 ).…”

An Activatable Semiconducting Nanoprobe for Early and Accurate Diagnosis of Liver Injury

“…Liver injury, a critical health condition, manifests through the damage of liver cells, which can lead to severe diseases such as cirrhosis, liver failure, or liver cancer. − It is commonly associated with various causes such as viral hepatitis, alcohol abuse, nonalcoholic fatty liver disease, and adverse drug reactions. − As the liver plays a central role in metabolism, detoxification, and the synthesis of vital proteins, its damage is a major concern for healthcare professionals. Clinical detection methods primarily rely on biochemical markers such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and liver biopsies. , However, current methods depending on blood analysis or biopsies are static and invasive.…”